logo

For the Inventor, By the Inventor

Yonkers, NY, United States of America

Aureon Laboratories, Inc.


USPTO Granted Patents = 12

% Expired Patents = 16.7


Forward Citations = 287

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Olivier Saidi (9 out of 9 patents)

silverMedal David Verbel (7 out of 12 patents)

bronzeMedal Mikhail Teverovskiy (4 out of 4 patents)

4.  Michael Donovan (2 out of 9 patents)

5.  Angeliki Kotsianti (2 out of 2 patents)

6.  Paola Capodieci (2 out of 3 patents)

7.  Lian Yan (2 out of 2 patents)

8.  Stefan Hamann (1 out of 2 patents)

9.  Ali Tabesh (1 out of 3 patents)

10.  Marina Sapir (1 out of 1 patent)

11.  Faisal M Khan (1 out of 1 patent)

12.  Jon Edelson (1 out of 2 patents)

13.  Mark Clayton (1 out of 14 patents)

14.  David A Verbel (0 patent)


12 patents:

1. 8093012 - Multiplex in situ immunohistochemical analysis (2012-01-10),
2. 8062897 - Diagnostic histopathology using multiplex gene expression FISH (2011-11-22),
3. 7933848 - Support vector regression for censored data (2011-04-26),
4. 7761240 - Systems and methods for automated diagnosis and grading of tissue images (2010-07-20),
5. 7702598 - Methods and systems for predicting occurrence of an event (2010-04-20),
6. 7599893 - Methods and systems for feature selection in machine learning based on feature contribution and model fitness (2009-10-06),
7. 7505948 - Support vector regression for censored data (2009-03-17),
8. 7483554 - Pathological tissue mapping (2009-01-27),
9. 7467119 - Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition (2008-12-16),
10. 7461048 - Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition (2008-12-02),
11. 7321881 - Methods and systems for predicting occurrence of an event (2008-01-22),
12. 6995020 - Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization (2006-02-07),
Company Overview
Aureon Laboratories, Inc. is a biotechnology company based in Yonkers, NY, specializing in advanced diagnostic solutions. The organization focuses on developing innovative technologies for the analysis of biological samples, particularly in the fields of cancer diagnostics and personalized medicine. By leveraging proprietary methodologies, Aureon aims to enhance the accuracy of disease detection and treatment strategies, contributing to improved patient outcomes and advancing the field of molecular diagnostics.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

12 Patents

#13 in Yonkers, NY

#1,488 in New York

#25,578 in US

#48,209 in the World

Yonkers, NY (US)
Yonkers, NY, United States of America

Aureon Laboratories, Inc.

Forward Citations = 287

13 inventors:

goldMedal Olivier Saidi (9 out of 9 patents)

silverMedal David Verbel (7 out of 12 patents)

bronzeMedal Mikhail Teverovskiy (4 out of 4 patents)

4.  Michael Donovan (2 out of 9 patents)

5.  Angeliki Kotsianti (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aureon Laboratories, Inc.. Retrieved from https://idiyas.com/company/aureon-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…